The Sahlgrenska Anti-VEGF Study

Exclusion Criteria

• •Other eye disease in the current study eye that affects visual acuity or the possibility of examining fundus, according to the investigator's assessment.
• •Previously received treatment for the neovascular (wet) form of age-related macular degeneration.
• •Diagnosed with diabetes (all types).
• •Degenerative state of the macula that prevents vision improvement such as central areolar atrophy or other pronounced dry AMD or fibrosis, in the current study eye.
• •Other choroidal neovascularization (CNV) of the type PCV or due to grave myopia i.e. ≥ 6.0 diopters (D) or secondary to other retinal disease, in the current study eye.
• •Unregulated intraocular pressure (IOP) \> 30 mmHg despite pharmacological treatment in the current study eye.
• •Have had a stroke or heart attack ≤6 months ago.
• •Inability to access information (e.g. due to dementia) or inability to conduct examinations (e.g. ETDRS examination), according to the investigator's assessment.
• •Inability to receive oral and written information in Swedish (in need of an interpreter).
• •Included in another intervention study.
• •Fertile woman i.e. a woman who has had menstruation for the past 12 months or has not undergone permanent sterilization (hysterectomy, bilateral salpingectomy or bilateral oophorectomy).